Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

NCT ID: NCT06908629

Last Updated: 2025-08-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-03

Study Completion Date

2027-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this screening study is to determine the feasibility of completing a social needs screening tool in participants who have a past or current cancer diagnosis and reside in Metro Detroit, Michigan. Main questions to answer are:

* Can we have a completion rate of at least 80% of participants filling out the screening tool?
* Can we determine procedures for patient referrals based on social needs
* Can we implement brief interventions based on food access and digital inclusion (ensuring everyone has access to the digital technologies they need to participate in society)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In part 1 of the study, Participants will be administered a social screening tool either in person or via telephone. Responses to the screening tool will be translated into diagnosis codes which identify non-medical factors that may influence a patient's health status. In part 2 of the study, participants will be referred to community-based resources based on their responses to the social needs screening tool. Follow up will be made via telephone call at 2, 4, 6 and 8 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Cancer Survivors Gastrointestinal Cancers Neuroendocrine Tumors Multiple Myeloma, Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Screening Needs Assessment

Group Type EXPERIMENTAL

Implementation of social determinants of health screening and referral

Intervention Type OTHER

Participants will be referred to community-based resources in response to their answers on the screening tool.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Implementation of social determinants of health screening and referral

Participants will be referred to community-based resources in response to their answers on the screening tool.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older
* past or current cancer diagnosis
* reside in metropolitan Detroit (Wayne, Oakland, Macomb counties)
* English proficient
* Actively receiving care through one of Karmano's Cancer Institute's outpatient clinics OR post treatment survivors in the Detroit Research on Cancer Survivors (ROCS) longitudinal cohort study who have reported past food insecurity and agreed to be contacted for further research

Exclusion Criteria

* none
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Barbara Ann Karmanos Cancer Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hayley Thompson

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Karmanos Cancer Institute

Detroit, Michigan, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hayley S Thompson, Ph.D.

Role: CONTACT

313-576-9734

Afsana Rinky

Role: CONTACT

313-576-9734

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hayley S. Thompson, PhD

Role: primary

313-576-9734

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-042

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.